Hybridoma cell line secreting an ActA monoclonal antibody and use thereof
AssigneeYangzhou University
InventorsXinan Jiao, Yuelan Yin, Mengdi Zhao, Fanzeng Meng, Xiang Chen, Jinlin Huang, Zhiming Pan, Dan Gu
Life of this patent
Estimating the term…
Loading patent…
AssigneeYangzhou University
InventorsXinan Jiao, Yuelan Yin, Mengdi Zhao, Fanzeng Meng, Xiang Chen, Jinlin Huang, Zhiming Pan, Dan Gu
Estimating the term…
A hybridoma cell line secreting an ActA monoclonal antibody and a use thereof. The hybridoma cell line was deposited on Jul. 8, 2021, at the China Center for Type Culture Collection (CCTCC) with the depository accession number of CCTCC NO: C2021174. The present invention also discloses the ActA monoclonal antibody secreted by this hybridoma cell line or its progeny cell line, a detection kit containing this ActA monoclonal antibody, immunomagnetic beads, the preparation method and use of immunomagnetic beads, and competitive ELISA and indirect ELISA detection methods. The ActA monoclonal antibody of the present invention has the advantages of high titer, good specificity, and strong affinity with the natural antigen. The Listeria competitive ELISA detection kit and immunomagnetic beads developed based on this antibody have high sensitivity and good stability, effectively monitoring the level of ActA antibodies in clinical serum samples, and can be used for labeling Listeria monocytogenes.
A competitive ELISA detection kit for detecting Listeria monocytogenes infection, comprising an Actin assembly-inducing protein (ActA) monoclonal antibody or a polynucleotide;
Dependencies are inferred from the claim text.